Summary

News of the week:

• The “America First” policy and hunger: According to the prestigious magazine *The Atlantic*, Somalia is experiencing a hunger emergency. For the first time in decades, the U.S. is taking no action.

The most significant healthcare news of the week:

• Biomedicine: Will we cure cancer soon? Only 5–10% of cancers are hereditary. Infections are responsible for a high percentage of cases, and obesity is a major risk factor.
• Global health: The U.S. global health strategy hinders pandemic prevention.
• International health policy: John Kerry calls Trump the “biggest loser,” accusing him of ceding leadership in the fight against climate change to China.
• National health policy: The number of foreign-trained physicians admitted to medical residency programs (MIR) has surged by 150%, now accounting for nearly half of the 2027 cohort.
• Industry: Big Pharma aims to stop Alzheimer’s before it develops.

Biomedicine

• Will we cure cancer soon? Only 5–10% of cancers are hereditary. Infections are responsible for a high percentage of cases, and obesity is a major risk factor.
• Scientists are finally beginning to understand endometriosis—a condition that is difficult to diagnose and treat, affecting 190 million people. Recent research offers faster diagnostic methods and more effective treatments.
• Next-generation healthcare robots will become part of the care team, according to an article published in *Nature*.
• A new brain atlas promises to lead to discoveries regarding various conditions, including Parkinson’s disease, schizophrenia, and autism.
• A study reveals that 100% of people carry genetic variants that alter how they respond to medications. A study has analyzed the complete genomes of 98,500 individuals and found that every single one of them carried genetic variants that influence how the body responds to common medications, such as omeprazole or atorvastatin.

Global Health

• The U.S. global health strategy hinders pandemic prevention. The Trump administration negotiated individually with many governments; according to experts, a global agreement would have been far more effective.
• Preventing malaria infections and the path toward eradication. In 2024, malaria caused more than 600,000 deaths, primarily among children in Africa.
• The Democratic Republic of the Congo has recorded nearly 11,000 cases of Ebola in less than six months.

International Health Policy

• The “America First” approach and hunger. According to the prestigious magazine *The Atlantic*, Somalia is facing a hunger emergency—and for the first time in decades, the U.S. is taking no action.
• American workers are seeing an increase in healthcare costs. Employer-sponsored insurance, which covers 157 million Americans, is the cornerstone of the U.S. healthcare system; as premiums rise, companies are increasingly shifting more of the cost onto their employees.
• The U.S. has lost its measles-free status. Genetic data confirm that the virus is circulating within the country.
• Health and poverty: lessons from China. Poverty is not merely an economic issue; it is also a health issue.
• The UK should leverage NHS data to advance artificial intelligence, a government minister argues, noting that the UK holds a competitive advantage in this field.
• “Medical deserts” in France: the government plans to launch 100 mobile medical units by 2027. These mobile clinics will provide consultations in areas that lack medical resources.
• What does a victory for the political left mean for universal healthcare systems globally? Lula’s victory halts the privatization efforts of the right-wing candidate, but it does not resolve the underlying problems within the system.
• John Kerry identifies Trump as the biggest loser for undermining climate action, accusing him of ceding leadership in the fight against climate change to China.
• Physicians are asserting their role in addressing professional challenges, citing a global “lack of political leadership.” The 9th Convention of the Medical Profession brought together representatives from European and Latin American countries, as well as the World Medical Association, united by a call for professional solidarity to pursue goals such as self-regulation of working conditions.
• More than 22 million Europeans may have undiagnosed diabetes; the European Parliament is calling for increased prevention and screening efforts. Over 43% of adults with diabetes—approximately 252 million people—remain undiagnosed.

National Health Policy (Spain)

• The number of foreign-trained physicians admitted to the MIR (medical residency training program) has surged by 150%, now accounting for nearly half of the 2027 intake. This coincides with an alarming rise in the number of foreign medical degree recognitions.
• The PP (People’s Party) has proposed a national state pact to reduce waiting lists.
• •Feijóo proposes a 10-year National Mental Health Plan, featuring guaranteed funding and an increase in the number of professionals.
• The PSOE has unveiled its platform, with key proposals including the elimination of waiting lists, the expansion of oral healthcare, and a preference for direct public management of health services.
• The Ministry of Health has launched a public consultation regarding the assessment of health technologies. Citizens, organizations, and interested associations may submit their input until November 30, 2026.
• 82% of residents in the Madrid region approve of the public healthcare system, with many highlighting the option for free choice of provider. An Ipsos study rates the Madrid public healthcare system at 6.5 out of 10—above the national average.
• Earlier diagnosis of diabetes remains a challenge in Spain; 1.65 million people are unaware that they have the condition. According to the latest International Diabetes Federation Atlas, approximately 4.7 million people aged 20 to 79 were living with diabetes in Spain in 2024.

Companies

• International

o              “Big Pharma” aims to halt Alzheimer’s disease before it develops. Roche is leading this effort, alongside other companies.

• Domestic

o              The decline in public healthcare has driven a 36% surge in private health insurance. The drop in the quality of public services has led to a 36% increase in the number of Spaniards with private health insurance over the past two years. This expansion has accelerated since 2023, with 24% of the Spanish population now covered by private insurance, according to data from the 2025 Health Survey.

Biomedicine

• From reactive to predictive medicine. 21st-century medicine focuses on monitoring and data analysis—raising the question of to what extent citizens will consent to share their data for their own benefit and that of the community. calls for a new social contract (https://elpais.com/extra/eventos/2026-11-07/la-salud-receta-un-nuevo-contrato-social.html)
• We should be cautious regarding campaigns by pharmaceutical companies aimed at destigmatizing obesity, as they often implicitly promote pharmacological treatment while sidelining other forms of intervention (https://www.bmj.com/content/395/bmj-2026-101360)
• The blood-brain barrier may contribute to cognitive function. In an article published in *Cell*, researchers highlight the protective role this barrier plays for the brain (https://www.economist.com/science-and-technology/2026/11/11/the-blood-brain-barrier-may-contribute-to-cognitive-function)
• Scientists are finally beginning to understand endometriosis—a condition that is difficult to diagnose and treat, and which affects 190 million people. Recent research offers a faster diagnostic method and more effective treatments (https://www.economist.com/science-and-technology/2026/11/09/scientists-are-at-last-starting-to-understand-endometriosis)
• Next-generation healthcare robots will become part of the care team, according to an article published in *Nature* (https://www.nature.com/articles/d42473-026-00203-4)
• Is grip strength a useful indicator of health? (https://www.economist.com/science-and-technology/2026/11/06/is-grip-strength-a-useful-indicator-of-health)
• Will we cure cancer soon? Only 5–10% of cancers are hereditary. Infections are responsible for a high percentage of cases. Obesity is a significant risk factor (https://www.ft.com/content/2645c02e-b3e1-4a0e-80d1-e848ecc1acf0?syn-25a6b1a6=1)
• What to know about the new recommendations for prostate cancer screening, published by the American Cancer Society (https://www.nytimes.com/2026/11/12/well/prostate-cancer-screening-guideline.html)
• New research compares the long-term benefits of 21 antidepressants. The meta-analysis finds that only a few of these medications are effective in the long term (https://www.nytimes.com/2026/11/10/well/mind/antidepressants-efficacy-work.html)
• A new brain atlas promises fresh insights into various conditions, including Parkinson’s disease, schizophrenia, and autism (https://www.ft.com/content/e9ce1070-0c61-450a-ac75-ddabb0edfa69?syn-25a6b1a6=1)
• Brain cancer: a breakthrough in decoding glioblastoma. An article published in *Nature* opens the door to new forms of treatment (https://sante.lefigaro.fr/medecine/cancer-du-cerveau-une-percee-dans-le-decodage-du-glioblastome-20261108). Access the original article in *Nature*
• •A study reveals that 100% of people carry genetic variants that alter the effect of medications. Research analyzing the complete genomes of 98,500 individuals found that every single one of them carried genetic variants that influence how common drugs—such as omeprazole or atorvastatin—behave in the body (https://www.elespanol.com/invertia/observatorios/sanidad/20261112/estudio-revela-personas-porta-variantes-geneticas-modifican-efecto-medicamentos/1003744454530_0.html). Access the original article in *Science*: https://www.science.org/doi/10.1126/scitranslmed.adt8040
• Science’s *mea culpa* reaches the cover of *Science* magazine: 146 years of studying women as if they were men. In a landmark issue, the prestigious journal acknowledges that, for decades, medicine has used the male body as the universal model (https://www.articulo14.es/salud/el-mea-culpa-de-la-ciencia-llega-a-la-portada-de-science-146-anos-investigando-a-las-mujeres-como-si-fueran-hombres-20261023.html). Access the original article in *Science*: https://www.science.org/doi/10.1126/science.aem4087
• Stopping medications in the Ozempic family: what a new study reveals about cardiovascular risk. The main finding was that discontinuation was associated with approximately double the incidence of a composite outcome consisting of non-fatal heart attack, non-fatal stroke, or death from any cause (https://www.elconfidencial.com/salud/2026-11-10/dejar-farmacos-ozempic-nuevo-estudio-riesgo-cardiovascular-1qrt_4462110/). Access the original article in *Science*: https://www.science.org/doi/10.1126/scitranslmed.adt8040
• Injecting a virus into the brain to curb epileptic seizures. Three patients with drug-resistant epilepsy experienced a 90% reduction in the number of seizures during the initial phase of a promising clinical trial that combines gene editing with medication (https://www.eldiario.es/sociedad/inyectar-virus-cerebro-frenar-ataques-epilepsia_1_13658192.html). Access the original article in the *NEJM*: https://www.nejm.org/doi/abs/10.1056/NEJMc2606815?referrer=https%3A%2F%2Fwww.eldiario.es%2F

Global Health

• Preventing malaria infections and the path toward elimination. Malaria caused more than 600,000 deaths in 2024, primarily among African children (https://www.nejm.org/doi/full/10.1056/NEJMra2508563)
• Mass survival through AI: a new determinant of health? Medicine has an obligation to consider this new perspective (https://www.nejm.org/doi/full/10.1056/NEJMp2611224)
• Lessons from the Ebola vaccine (https://www.science.org/doi/10.1126/science.aem8493)
• Innovations in biotechnology—especially in agriculture—offer an opportunity to limit climate change (https://www.nature.com/articles/d41586-026-03621-y)
• The U.S. global health strategy hinders pandemic prevention. The Trump administration has negotiated individually with many governments; according to experts, a global agreement would have been far more effective (https://www.nytimes.com/2026/11/06/us/politics/pandemic-prevention-african-countries.html)
• The Democratic Republic of the Congo has recorded nearly 11,000 Ebola cases in less than six months (https://theobjective.com/internacional/2026-11-10/rd-congo-11-000-casos-ebola-menos-de-seis-meses/)
• Vaccines4Children provides vaccines to more than 13 million children in Africa. The ‘La Caixa’ Foundation and Gavi are mobilizing funds for childhood vaccination against pneumonia in Africa (https://www.eleconomista.es/salud-bienestar/noticias/14026795/11/26/vaccines4children-facilita-vacunas-a-mas-de-13-millones-de-ninos-en-africa.html)

International Health Policy

• USA

o              The “America First” policy and hunger. According to the prestigious magazine *The Atlantic*, Somalia is experiencing a famine emergency. For the first time in decades, the U.S. is taking no action (https://www.theatlantic.com/health/2026/11/famine-somalia-trump-aid/689295/)

o              Anthony Fauci in London. Dr. Fauci delivered the University College London Prize lecture to an audience of academics—receiving applause—while anti-vaccine protesters gathered outside. His core message emphasized the ongoing danger posed by infectious diseases (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02284-1/fulltext)

o              American workers face rising healthcare costs. Employer-sponsored insurance, which covers 157 million Americans, serves as the cornerstone of the U.S. healthcare system. As insurance premiums increase, companies are shifting a larger share of the cost onto their employees (https://www.economist.com/united-states/2026/11/10/american-workers-face-a-surge-in-health-costs)

o              The U.S. has lost its measles-free status. Genetic data confirm that the virus is spreading within the country (https://www.nytimes.com/2026/11/10/health/measles-united-states-elimination-rfk.html)

o              Pennsylvania and Wisconsin report deaths of children due to measles (https://www.reuters.com/business/healthcare-pharmaceuticals/pennsylvania-reports-seventh-measles-linked-death-cases-rise-2026-11-13/)

o              RFK Jr. has failed the U.S. regarding measles. The virus is once again endemic in the USA (https://www.theatlantic.com/health/2026/11/measles-elimination-status-endemic-kennedy/689450/)

• China

o              Health and poverty: lessons from China. Poverty is not just an economic issue, but also a health issue (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02186-0/fulltext). Access the full report from The Lancet: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01196-7/abstract

• United Kingdom

o              The UK must leverage NHS data to boost AI, says a minister, noting that the UK holds a competitive advantage in this field (https://www.ft.com/content/f95d9298-d27e-4c1b-87e5-ea75f67a1e0c?syn-25a6b1a6=1)

o              What does prevention look like in practice? It is essential to understand how the NHS approaches prevention (https://www.kingsfund.org.uk/insight-and-analysis/long-reads/what-prevention-look-like-practice)

• France

o              Near Nice, a new cutting-edge heart institute, 100% funded through philanthropy. With a cost of 130 million, the center has not received any public funding (https://www.lemonde.fr/economie/article/2026/11/11/pres-de-nice-un-nouvel-institut-du-c-ur-a-la-pointe-de-la-technologie-finance-a-100-par-la-philanthropie_6808997_3234.html)

o              In France, 659 deaths were linked to the consumption of drugs or medications in 2024—a 171% increase over ten years (https://www.lemonde.fr/societe/article/2026/11/10/en-france-le-nombre-de-morts-liees-a-la-consommation-de-drogues-ou-de-medicaments-a-augmente-de-171-en-dix-ans_6808807_3224.html)

o              Addressing “medical deserts,” the government plans to launch 100 “medical buses” by 2027. These mobile units offer consultations in areas that lack medical resources (https://www.lemonde.fr/societe/article/2026/11/09/deserts-medicaux-le-gouvernement-veut-atteindre-100-medicobus-labellises-en-2027_6808654_3224.html)

• Argentina

o              Cuts to the “Remediar” program—designed to provide free essential medicines at primary care centers—have become the subject of a legal challenge (https://www.geocontexto.com/?id=217125&view=noticia&utm_source=chatgpt.com)

• Brazil

o              What does the victory of… mean? …the left regarding universal healthcare systems globally? Lula’s victory halts the privatization attempts proposed by the right-wing candidate, but it does not resolve the existing problems within the system (https://www.bmj.com/content/395/bmj-2026-101419)

o              Mpox cases are on the rise, and new vaccination efforts are being considered. The state of Rio de Janeiro has three times as many cases as it did in 2025 (https://www1.folha.uol.com.br/equilibrioesaude/2026/11/brasil-ultrapassa-mil-casos-de-mpox-e-registra-uma-morte-no-rio.shtml)

• Chile

o              The future of concession-based hospitals is under discussion. During Exposalud 2026, COPSA and the Chilean Chamber of Construction brought together representatives from the public and private sectors to analyze the development of concession-based hospitals, the challenges surrounding new tender processes, and the experience gained during the pandemic (https://www.emol.com/noticias/Tendencias/2026/11/09/1216589/futuro-hospitales-concesionados.html?utm_source=chatgpt.com)

• Colombia

o              Dengue fever is becoming an increasing concern (https://www.minsalud.gov.co/Comunicaciones/noticias/2026/Paginas/MinSalud-intensifica-acciones-contra-el-dengue-ante-el-aumento-del-riesgo-por-el-Fenomeno-de-El-Nino.aspx)

• •Australia

o              Australia signs up to the EU’s Horizon Europe research program (https://www.politico.eu/article/australia-signs-up-to-eus-horizon-europe-research-program/)

• COP31

o              Trump is the biggest loser for undermining climate action, says John Kerry, who accuses Trump of ceding leadership in the fight against climate change to China (https://www.theguardian.com/environment/2026/nov/12/trump-loser-john-kerry-cop31)

o              You cannot build peace on a burning planet, says UN Secretary-General António Guterres at COP31 (https://www.theguardian.com/environment/2026/nov/13/cop31-antonio-guterres-united-nations-climate-action)

• 9th Convention of the Medical Profession

o              Physicians assert their role in addressing professional challenges in the face of a global “lack of political leadership.” The 9th Convention of the Medical Profession brings together representatives from European and Latin American countries, as well as the World Medical Association, with a shared message of professional unity. Their goal is to achieve objectives such as self-regulation of working conditions (https://isanidad.com/394830/medicos-se-reivindican-para-gestionar-problemas-profesion-ante-carencia-clase-politica-nivel-mundial/)

• European Union

o              Building a European Framework for Neurological Health. The goal is to have a strategic framework for neurological diseases in place by 2031 (https://www.politico.eu/sponsored-content/building-a-european-neurological-health-framework/)

o              European cities are calling for a total ban on cigarette filters (https://www.politico.eu/article/european-cities-demand-total-eu-ban-cigarette-filters/)

o              More than 22 million Europeans may have diabetes without knowing it; the European Parliament is calling for increased prevention and screening. Over 43% of adults with diabetes—approximately 252 million people—remain undiagnosed (https://www.consalud.es/pacientes/mas-de-22-millones-de-europeos-podrian-tener-diabetes-sin-saberlo-la-eurocamara-exige-mas-prevencion-y-cribados.html)

National Healthcare Policy

• Healthcare proposals ahead of the November 29th elections

o              The PP proposes a national pact to reduce waiting lists (https://www.elconfidencial.com/salud/2026-11-09/el-pp-propone-un-pacto-de-estado-reducir-las-listas-de-espera_4460685/)

o              Feijóo proposes a 10-year National Mental Health Plan with guaranteed funding and an increase in the number of professionals (https://medicinaresponsable.com/politica-sanitaria/feijoo-promete-plan-nacional-salud-mental-financiacion-garantizada-profesionales)

o              The PP proposes the creation of a State Fund for Innovation in Rare Diseases and Advanced Therapies (https://gacetamedica.com/politica/pp-fondo-estatal-innovacion-enfermedades-raras-terapias-avanzadas/)

o              Feijóo promises to improve working conditions for physicians, increase the number of doctors in primary care, and introduce a new professional classification system (https://www.diariomedico.com/medicina/politica/feijoo-promete-mejorar-condiciones-medico-mas-facultativos-ap-nueva-clasificacion-profesional.html)

o              The PSOE has released its platform, with key proposals including ending waiting lists, expanding oral healthcare, and prioritizing direct public management of services (https://www.psoe.es/media-content/2026/11/PROGRAMAPSOE29N26.pdf)

• Central Government

o              Green light for the new dependency care model: the government approves 7.24 billion euros for 2027. Protection for single-parent families is being expanded. (https://www.elespanol.com/invertia/observatorios/sanidad/20261110/luz-verde-nuevo-modelo-dependencia-gobierno-aprueba-millones-transformar-cuidados/1003744452491_0.html)

o              The Ministry of Health has opened a public consultation on the assessment of health technologies. Interested citizens, organizations, and associations may submit their input until November 30, 2026 (https://elglobalfarma.com/politica/sanidad-consulta-publica-desarrollar-instrucciones-evaluacion-tecnologias-sanitarias/)

o              The Ministry of Health sees a potential agreement to fund new Alzheimer’s medications. This was announced by César Hernández at the “II Farma Futura 2026” meeting (https://theobjective.com/sanidad/2026-11-06/sanidad-financiar-nuevos-medicamentos-alzheimer/)

• Regional Administrations

o              From guaranteeing access to biomarkers to measuring outcomes: Catalonia’s new challenge. Catalonia has established a model for equitable access to oncology biomarkers, but it now faces new challenges in improving care pathways, incorporating new technologies, and evaluating the real-world outcomes of precision medicine (https://diariofarma.com/2026/11/11/de-garantizar-los-biomarcadores-a-medir-sus-resultados-el-nuevo-desafio-de-cataluna)

o              82% of residents in the Madrid region approve of the public healthcare system, with many highlighting the option for free choice of healthcare provider. An Ipsos study places the average rating for the healthcare system in the Madrid region at 6.5 out of 10, which is above the national average (https://theobjective.com/sanidad/2026-11-11/madrilenos-sanidad-publica-eleccion-sanitaria/)

• MIR (Medical Residency Training) Call for Applications

o              The number of foreign-trained physicians admitted to the MIR program has surged by 150%, now accounting for nearly half of the 2027 cohort. This coincides with an alarming increase in the number of foreign medical degree recognitions (homologations) (https://www.elespanol.com/invertia/observatorios/sanidad/20261114/medicos-extranjeros-admitidos-mir-disparan-suponen-mitad-convocatoria/1003744457819_0.html)

o              The MIR program has reached a record number of admissions: 5,600 more people than last year. A total of 40,074 individuals—21,668 of whom hold a medical degree—have been provisionally admitted to the 2027 Specialized Healthcare Training (MIR) program (https://www.consalud.es/formacion/mir/el-mir-de-2027-bate-su-record-de-inscritos-5600-personas-mas-que-el-ano-pasado.html)

• New Terminology for Hospitals and Insurance Companies

o              Hospitals and insurance companies have agreed on a catalog of terms to clarify concepts. The private healthcare sector is seeking a common language to clarify what each service includes, reduce discrepancies, and free up resources currently spent on reviewing documentation and reconciling payments (https://www.elmundo.es/salud/2026/11/12/6af5697f21efa02e708b4572.html)

• Diabetes

o              Earlier diagnosis of diabetes—a challenge in Spain: “1.65 million people are unaware they have it.” According to the latest Atlas from the International Diabetes Federation, approximately 4.7 million people aged 20 to 79 were living with the disease in Spain in 2024 (https://www.consalud.es/pacientes/adelantar-el-diagnostico-de-la-diabetes-un-reto-en-espana-165-millones-de-personas-desconocen-que-la-padecen.html)

• Social Security and menstruation
• The Social Security system grants medical leave—at 75% of the regulatory base—to workers experiencing debilitating menstrual pain, even in cases where no prior social security contributions have been made (https://www.eleconomista.es/economia/noticias/14027682/11/26/la-seguridad-social-concede-una-baja-con-el-75-de-la-base-reguladora-a-las-trabajadoras-con-menstruaciones-incapacitantes-incluso-sin-cotizaciones.html)

Companies

• International

o              Manufacturers of anti-obesity drugs push back against allegations of adverse effects. Both Lilly and Novo respond to claims that their blockbuster anti-obesity medications cause health issues (https://www.ft.com/content/acca0ba8-913d-4a8a-8d3b-a5521ed1cfc2?syn-25a6b1a6=1)

o              Villarreal: “Up to a third of people classified as obese are receiving medication despite not being ill.” Research published in *Nature* challenges the use of Body Mass Index (BMI) and proposes a two-step system that determines whether excess body mass is already causing organ damage (https://www.abc.es/salud/tercio-personas-clasificadas-obesidad-reciben-farmacos-estar-20261111170001-nt.html)

o              Pfizer secures $1.5 billion from Blackstone for the development of diabetes medications (https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-secures-up-15-billion-blackstone-obesity-drug-development-2026-11-11/)

o              Lilly becomes the first pharmaceutical company to have a GLP-1 pill approved in China (https://www.reuters.com/business/healthcare-pharmaceuticals/china-approves-eli-lillys-weight-loss-pill-orforglipron-2026-11-12/)

o              Big Pharma aims to stop Alzheimer’s disease before it develops. Roche is leading this movement, alongside other companies (https://www.ft.com/content/df3c778f-3a55-45af-a154-94631478120b?syn-25a6b1a6=1)

o              Siemens Healthineers is spinning off its in vitro diagnostics business under the name Olyrian Diagnostics (https://www.elespanol.com/invertia/observatorios/sanidad/20261112/siemens-healthineers-separa-negocio-diagnostico-in-vitro-nuevo-nombre-olyrian-diagnostics/1003744455563_0.html)

• Domestic (Spain)

o              The deterioration of the public healthcare system has driven a 36% surge in private health insurance. A decline in the quality of public healthcare has led to a 36% increase over the last two years in the number of Spaniards with private health insurance. This expansion has been most pronounced since 2023, with 24% of the Spanish population now covered, according to data from the 2025 Health Survey (https://www.eldiario.es/economia/deterioro-sanidad-publica-dispara-36-seguro-privado_129_13644560.html)

o              Fresenius is accelerating its exit from the dialysis business, involving 42 clinics in Spain. The transaction reduces its stake in the global dialysis giant from 25% to approximately 20% (https://www.eleconomista.es/salud-bienestar/noticias/14027253/11/26/el-dueno-de-quironsalud-acelera-su-salida-del-negocio-de-dialisis-con-42-clinicas-en-espana.html)

o              Almirall boosts profit by 36% alongside an 8.2% increase in revenue, and reaffirms its forecasts (https://cincodias.elpais.com/companias/2026-11-09/almirall-eleva-el-beneficio-un-36-con-un-aumento-de-ingresos-del-82-y-confirma-previsiones.html)

o              Adeslas, Sanitas, and Asisa widen the gap with their rivals in the healthcare sector. The trio has increased premium revenue at a nearly identical rate among themselves—a growth that is more pronounced than that of their direct competitors, Mapfre and DKV (https://www.expansion.com/empresas/2026/11/09/adeslas-sanitas-asisa-amplian-brecha-rivales-salud.html)

This post is also available in: